- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanomix, Inc., a leading nanoelectronic detection company commercializing high-value diagnostic and monitoring applications, today announced the issuance of an additional U.S. patent for its nanostructured detection platform known as Sensation(TM).
This patent (US Patent No. 7,312,095, issued December 25, 2007) includes broad claims to methods of making arrayed nanostructured sensing devices which are chemically functionalized to respond to chosen target substances. In particular, the claims include arrays with integrated reference sensors, arrays with sensors individually functionalized with chemical jets, and particular electrochemical functionalization methods. With the addition of this patent, Nanomix now owns patents covering two important concepts for nanosensor arrays, including one for multiplex detection which allows selectivity, and one for referenced detection which permits more accurate response via self calibration.
Detection devices of this type use nanostructured materials as extremely sensitive transducers to permit accurate and selective measurement of chemicals and bioanalytes. The devices have extremely low power requirements and are scalable for mass production using conventional wafer processing technology.
"We are excited to see this addition to our growing patent portfolio related to nanoelectronic detection," said David Macdonald, President and CEO of Nanomix. "This patent combined with others in our IP estate provides competitive advantages and important protection for our respiratory and biomolecule detection products."
About Nanomix, Inc.
Nanomix is a leading electronic detection company launching detection devices based on Sensation(TM) technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across high value respiratory and biomarker detection applications where low power consumption, small size, and ultra-sensitivity offer significant performance advantages and enable unprecedented access to critical information.
For more information, please click here
Vice President of Business Development, Marketing and Sales
Copyright © MarketwireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Heat-Converting Material Patents Licensed April 8th, 2015
From tobacco to cyberwood March 31st, 2015